Institute of Oncology Ljubljana
2 clinical trials · 2 recruiting · OTHER
Trials by Institute of Oncology Ljubljana
RECRUITINGNCT05878977
Biomarkers in Immunotherapy of Melanoma
Background: Immunotherapy has been successful in treating advanced melanoma, but a large proportion of patients do not respond to the treatment with immune checkpoint inhibitors...
Sponsor: Institute of Oncology LjubljanaEnrolling: 1501 location
Metastatic MelanomaImmune Checkpoints InhibitorsGastrointestinal Microbiome (Bacterial and Viral)+1
RECRUITINGNCT07407166
Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers
This study evaluates the effectiveness of first-line immunotherapy in patients with metastatic melanoma treated at the Institute of Oncology Ljubljana in Slovenia. The main...
Sponsor: Institute of Oncology LjubljanaEnrolling: 401 location
Metastatic MelanomaMelanoma